← All Purple Biotech LTD filings

Purple Biotech LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
PPBT
Purple Biotech LTD
20-F: Purple Biotech Reports Fiscal Year 2024 Results, Highlights Clinical Progress
Purple Biotech files its 20-F, reporting financial results for the year ended December 31, 2024, and outlining progress in its clinical-stage oncology programs.
NASDAQ
PPBT
Purple Biotech LTD
20-F: Purple Biotech Reports FY2023 Results, Highlights Oncology Pipeline Progress
Purple Biotech's FY2023 20-F filing details the company's financial standing, ongoing clinical trials, and strategic focus on developing oncology therapies.